Jul 2026· Orvosi Hetilap· Vol 167 30, pp.
1186-1198
· 0 citations· 29 references
Medicine
TL;DR
Based on the available literature, photon-counting detector computed tomography offers particular advantages in the detection and characterization of small pulmonary nodules, subsolid and ground-glass lesions, as well as in the assessment of fine morphological features of interstitial lung diseases.
Abstract
Computed tomography of the chest is a cornerstone imaging modality in the diagnosis of pulmonary diseases; however, conventional systems based on energy-integrating detectors have inherent physical limitations, including restricted spatial resolution, electronic noise, and reduced image quality at low radiation doses, which may compromise diagnostic accuracy in certain clinical scenarios. Photon-counting detector computed tomography represents a novel technological approach based on the individual detection and energy discrimination of incoming X-ray photons. This enables improved dose efficiency, reduced image noise, higher spatial resolution, and intrinsic spectral imaging from a single acquisition. The aim of this review is to provide an overview of the role of photon-counting detector computed tomography in pulmonary imaging. Based on the available literature, this technology offers particular advantages in the detection and characterization of small pulmonary nodules, subsolid and ground-glass lesions, as well as in the assessment of fine morphological features of interstitial lung diseases. In addition, it improves the visualization of infectious, vascular, and traumatic pulmonary abnormalities. Spectral imaging capabilities, including virtual monoenergetic reconstructions and iodine maps, provide additional functional information on tissue perfusion, lesion characterization, and treatment response. The technique also shows promise in interventional applications by improving the visualization of target lesions and interventional devices. Photon-counting detector computed tomography represents a significant technological advancement in lung imaging. However, its widespread clinical implementation is currently limited by restricted availability, high costs, and challenges related to inter-system comparability. Nevertheless, current evidence suggests that this technology will play an increasingly important role in pulmonary diagnostics in the future. Orv Hetil. 2026; 167(30): 1186-1198.
Spectral computed tomography (CT) has become an important extension of contrast-enhanced CT (CECT) in oncologic imaging by providing material-specific information beyond conventional morphologic assessment. Dual-energy CT (DECT), implemented on energy-integrating detector CT (EID-CT) platforms, has demonstrated the val...
Yusuke Kawasaki, Kota Yokoyama, Hiroto Hada et al.· Insights into Imaging· 0 citations
Positron emission tomography (PET) is an important molecular imaging modality in oncology because it provides functional and metabolic information that complements the anatomical information obtained from computed tomography (CT). However, the ability of PET to detect tumors is fundamentally determined by several physi...
Sayed Shafiq Hussain Mohammadi, Mohammad Zia Zahedi, Mohammad Yasin Mohammadi· International Journal of Cur...· 0 citations
Can photon-counting CT, with optimal spatial resolution, reduced noise and metal artifacts, and spectral capabilities, improve the visualization of complex head and neck anatomy?
T. Martín-Noguerol, Jorge Escartín, P. López-Úbeda et al.· European Radiology· 0 citations
Current evidence suggests that PCD-CT represents a transformative advancement in noninvasive coronary imaging, and may enhance clinical decision-making, reduce unnecessary downstream testing, and expand the role of CT in comprehensive cardiovascular assessment.
Roosha Parikh, Doosup Shin, Ziad A. Ali et al.· Current Opinion in Cardiolog...· 0 citations
While sharper kernels and lower monoenergetic bins increased noise and reduced CNRD, they significantly improved spatial resolution, achieving sub-millimeter feature detectability in one patient, supporting feasible lesion detectability under these thresholds.
Thyroid eye disease (TED) diagnosis is made based on the presence of a constellation of clinical, laboratory, and radiologic findings. Currently, computed tomography (CT) and magnetic resonance imaging (MRI) are the most commonly used imaging modalities; however, they provide indirect indicators of underlying inflammat...
Kelsey A. Roelofs, Kimberly M. Papp, Kate S. Lim et al.· Frontiers in Ophthalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.